Skip to main content

Picodya is happy to announce an expansion of our collaboration agreement with the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH). This collaboration will focus on developing new diagnostic assays for infectious and respiratory diseases.

Picodya CEO, Tzvika Barkai, stated “We are excited to expand our collaboration with NIAID to tackle some of the world’s most pressing health challenges. By combining our strengths in POC diagnostics and NIAID’s deep expertise in infectious diseases, we believe we can make a real difference in the lives of patients.”